Assessing the risk of hereditary breast cancer
Breast cancer is the most common cancer among women. In nearly 30 % of all cases, a member of the breast cancer patient’s extended family also has breast cancer. This may be coincidental or due to hereditary susceptibility.
According to estimates, a single gene mutation that runs in the family underlies approximately 5–10 % of all breast cancer cases. The most common form of such mutations are BRCA gene defects.
Indications of hereditary breast cancer include:
- Breast cancer in a very young person
- Multiple cancers in one person
- Breast cancer in both breasts
- Incidences of breast cancer and/or ovarian cancer in close kin
How can breast cancer heredity be examined?
How can the heredity of cancer be examined if you have a nagging doubt and have observed some of the indications mentioned above? At Docrates Cancer Center, we provide two alternative paths. A sensible approach is to discuss the cancer cases in your family with a specialist in medical genetics. If the situation seems to indicate the chance of hereditary breast cancer, a genetic test to investigate heredity will be recommended. The test is best suited for people who have actually already suffered from cancer. If a genetic defect is discovered, efforts will be made to identify all the carriers of the defective gene in the family. Even if a family shows hereditary susceptibility to cancer, it does not mean that all family members have inherited it.
However, if a customer wishes, another approach can also be adopted. A genetic risk test can be performed immediately on the basis of the customer’s concern or his or her own assessment, whereafter the situation and the significance of the test can be discussed with a geneticist when the results of the gene test are known. The interpretation of the results always depends on the patient’s and his or her family’s situation. In other words, if the genetic risk test does not reveal any harmful variant associated with an increased risk of developing cancer, it does not necessarily mean that the person in question could not have inherited cancer susceptibility, which is why he or she would require more accurate monitoring than usual.
PSA testing best method so far for early detection of prostate cancer – Pros and cons of PSA
PSA testing has its pros and cons. Should you have a PSA test?Read more
New blood test for prostate cancer diagnostics
Docrates Cancer Center is first in Finland to start using a new blood test supporting PSA-testing in prostate cancer A...Read more
Your safety is the most important to us
Many cancer patients have several concerns when it comes to the coronavirus pandemic, e.g. how does the situation impact my...Read more
Cancer and Coronavirus – FAQ
The coronavirus is a concern among cancer patients. We listed the most common concerns and the answers to them.Read more
Why come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay even during epidemic.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.